Covaxin receives approval for emergency use in 12-18 years old children
- In October, Subject Experts Committee (SEC) of country’s apex drug regulatory organisation Central Drugs Standard Control Organisation (CDSCO) had recommended granting emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for the age group 2-18 years